Abstract # P41 Clinical Success for Nepafenac Ophthalmic Suspension 0.1% Administered Before and After Cataract Surgery

Lane, Stephen
Associated Eye Care
Saint Paul, MN, United States of America

< Back to titles

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results

> Conclusions

> View additional images/videos

About the Presenter:
Stephen S. Lane M.D.

Stephen S. Lane, M.D. is a cornea/external disease fellowship trained board certified ophthalmologist and Clinical professor of ophthalmology at the University of Minnesota, Minneapolis Minnesota Dr. Lane is actively involved in clinical research having participated in over 35 national clinical trials investigating new products for cataract and refractive surgery.

Dr. Lane is past President of ASCRS. He is co-medical editor of EyeWorld and serves on the editorial board of the Journal of Cataract and Refractive Surgery, Evidence-Based Eyecare. He presently is Secretary of New Information for the AAO and serves on the Committee of Secretaries of the AAO.

In 1993, the AAO presented Dr. Lane with the Honor Award for teaching contributions and in 2002 received the American Academy of Ophthalmology Senior Achievement Award and Secretariat Award. Dr. Lane is a visiting faculty member of ORBIS International. Dr. Lane has presented at more than 15 named lectures and visiting professorships and has published more than 50 peer-reviewed ophthalmic papers. He has written chapters for or served as co-author of 20 books.

Stephen S. Lane, MD

Click on images to enlarge (a new pop-up window will open)

Clinical Success for Nepafenac Ophthalmic Suspension 0.1%:

E-mail a friend about this abstract:
Enter email address:   

Posters On Demand home page